APA (7th ed.) Citation

Huang, R., Zhang, C., Mo, X., Rao, H., & Jia, R. Outbreak of metabolic dysfunction-associated steatohepatitis pharmacotherapies in 2024: From resmetirom to tirzepatide. Wolters Kluwer.

Chicago Style (17th ed.) Citation

Huang, Rui, Chunli Zhang, Xiaodong Mo, Huiying Rao, and Rongman Jia. Outbreak of Metabolic Dysfunction-associated Steatohepatitis Pharmacotherapies in 2024: From Resmetirom to Tirzepatide. Wolters Kluwer.

MLA (9th ed.) Citation

Huang, Rui, et al. Outbreak of Metabolic Dysfunction-associated Steatohepatitis Pharmacotherapies in 2024: From Resmetirom to Tirzepatide. Wolters Kluwer.